Munafa Stock Market Course + Intraday & FNO calls 
DT NEWS why is Dynatrace Inc price falling or rising
DT NEWS reasons for why stock price of Dynatrace Inc is falling or rising
DT Dynatrace Inc is falling or rising technical reasons
Technical analysis forecast for Dynatrace Inc Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Dynatrace Inc DT at this time. Stock is falling and might fall more.
It appears as if Dynatrace Inc DT gave a large move recently.
Stock of Dynatrace Inc (DT) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Dynatrace Inc is bearish for shortterm, and stock might move down till 39.1 or till 37. Use a stoploss of 40.9 and if the stock hits stoploss, then it can shoot up till 42.67
DT Dynatrace Inc is falling or rising NEWS fundamental reasons
Pharma in her DNA, Wockhardt scion ready for deep dive in the US Zahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacterial infections and is a significant bet for the company. Zaynich's US approval marks a major breakthrough after decades - NEWS as on 2026-06-10 indiatimes.com
Pre-Market Earnings Report for June 3, 2026 : MDT, M, OLLI, THO, CGNT, CXM, VBNK The following companies are expected to report earnings prior to market open on 06/03/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Medtronic plc (MDT)is reporting for the quarter ending April 30, 2026. The medical produc - NEWS as on 2026-06-02 nasdaq.com
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff? Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for urinary tract infections. The company also reported a strong turnaround in its March quarter results. Revenue and prof - NEWS as on 2026-06-02 indiatimes.com
Wockhardt among 8 stocks hit 52-week highs, rally up to 55% in a month - NEWS as on 2026-06-01 indiatimes.com
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibiotic Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial results and the drug’s potential to treat severe drug-resistant infections boosted investor sentiment, helping the stoc - NEWS as on 2026-05-29 indiatimes.com
More announcements and NEWS
DT Dynatrace Inc current price & indicator signals
Recent prices of DT Dynatrace Inc are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 12 Fri Jun 2026 | 40.75 | 39.71 to 41.08 | 0.94% | 0.87 times |
| 11 Thu Jun 2026 | 40.37 | 39.73 to 41.14 | -0.52% | 0.93 times |
| 10 Wed Jun 2026 | 40.58 | 40.13 to 41.87 | -0.47% | 1.09 times |
| 09 Tue Jun 2026 | 40.77 | 39.91 to 41.90 | -2.74% | 1.27 times |
| 08 Mon Jun 2026 | 41.92 | 41.43 to 42.47 | -0.66% | 1.08 times |
| 05 Fri Jun 2026 | 42.20 | 41.91 to 43.96 | -2.43% | 0.44 times |
| 04 Thu Jun 2026 | 43.25 | 43.19 to 44.34 | -0.41% | 0.75 times |
| 03 Wed Jun 2026 | 43.43 | 42.94 to 45.45 | -3.42% | 0.68 times |
| 02 Tue Jun 2026 | 44.97 | 42.58 to 44.99 | 1.12% | 0.78 times |
| 01 Mon Jun 2026 | 44.47 | 42.54 to 44.84 | 4.41% | 1.44 times |
| 29 Fri May 2026 | 42.59 | 40.82 to 43.00 | 5.13% | 1.54 times |
| 28 Thu May 2026 | 40.51 | 39.17 to 40.80 | 4.11% | 1.02 times |
Videos related to: DT NEWS why is Dynatrace Inc price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
